BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 6276273)

  • 1. Intracellular "labyrinths" in acute leukaemia. Do they indicate the maturational ability of leukaemic cells?
    Lelkes G; Kelkes GY; Natonek K; Hollán SR
    Haematologia (Budap); 1981; 14(3):293-306. PubMed ID: 6276273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The mechanism of cell proliferation in acute (immature-cell) leukemia].
    Urasiński I; Kordecki H
    Acta Haematol Pol; 1977; 8(3):205-212. PubMed ID: 270271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The erythropoiesis in acute lymphoblastic leukaemia. A morphologic study.
    Sjögren U
    Lymphology; 1979 Dec; 12(4):225-7. PubMed ID: 294491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of adult acute leukemia by scanning electron microscopy and surface markers on the basis of the FAB classification (author's transl)].
    Yamada K; Okabe N; Uzuka Y
    Rinsho Ketsueki; 1982 Mar; 23(3):293-304. PubMed ID: 6955533
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine incorporation into leukaemic blast cells.
    Lange Wantzin G
    Biomedicine; 1979 Oct; 31(6):158-63. PubMed ID: 294296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Phi bodies in acute leukaemia.
    Cardullo Lde S; Morilla R; Catovsky D
    J Clin Pathol; 1981 Feb; 34(2):153-7. PubMed ID: 6262384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystalline inclusions in the cytoplasm and nuclei of cells of acute myeloid leukaemia.
    Pearson EC
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):311-9. PubMed ID: 2475413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell volume measurements in acute leukaemia: method and value for diagnosis and prognosis.
    Facquet-Danis J; Zittoun R; Bouchard M; Cadiou M; Bousser J; Bilski-Pasquier G
    Biomedicine; 1976 Sep; 25(8):294-8. PubMed ID: 1069593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific antibodies to viruses HL-23 and BILN in the blood plasma of patients with acute myelogenous leukaemia and with potential preleukaemia.
    Tóth FD; Kiss J; Váczi L; Madár Z; Jakó J; Rák K
    Acta Microbiol Acad Sci Hung; 1980; 27(2):147-53. PubMed ID: 6251702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lysine metabolism in acute leukemia].
    Hansz J
    Acta Haematol Pol; 1979 Oct; 10(4):237-42. PubMed ID: 295172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia.
    Liu E; Hjelle B; Morgan R; Hecht F; Bishop JM
    Nature; 1987 Nov 12-18; 330(6144):186-8. PubMed ID: 3313061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of monocytic leukaemia cutis in a patient with myelodysplastic syndrome transforming to acute myeloid leukaemia.
    Perez A; Kennedy C; Standen G; Oxley J
    Clin Exp Dermatol; 2004 Sep; 29(5):497-8. PubMed ID: 15347335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
    Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
    Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light green crystals in May-Grünwald and Giemsa-stained bone marrow macrophages in patients with myeloid leukaemia.
    Stavem P; Ly B; Bjorneklett A
    Scand J Haematol; 1977 Jan; 18(1):67-72. PubMed ID: 65789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytological features of acute leukaemia in the central region of Tunisia].
    Jmili NB; Ben Abdelaziz A; Nagara M; Mahjoub T; Ghannem H; Kortas M
    East Mediterr Health J; 2004; 10(4-5):640-7. PubMed ID: 16335657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.